Cite
MLA Citation
Matteo Lambertini et al.. “Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials.” Cancer, vol. 125, no. 2, 2019, pp. 307–316. http://access.bl.uk/ark:/81055/vdc_100076794511.0x000064